Key result
Treatment in the U.S. versus Canada yielded similar short-term mortality rates after acute myocardial infarction in the GUSTO-I trial.
Why the study?
Does treatment location (U.S. vs. Canada) affect long-term mortality after acute MI?
Does treatment location (U.S. vs. Canada) affect long-term mortality after acute MI?
Short-term mortality after acute MI was similar between the U.S. and Canada in the GUSTO-I trial.
Equivalence suggests comparable acute MI care delivery; leaves open long-term mortality differences and contemporary relevance.
In the GUSTO-I trial from the early 1990s, short-term mortality rates after acute MI were similar in the U.S. and Canada, even though cardiac
No takes yet. Share an insight, caveat, or question.
Howard C. Herrmann (2004) studied this question. Treatment in the U.S. versus Canada yielded similar short-term mortality rates after acute myocardial infarction in the GUSTO-I trial.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: